Human hepatic cell uptake of resveratrol: Involvement of both passive diffusion and carrier-mediated process

Biochemical and Biophysical Research Communications

Volumn 316, Issue 4, 2004, Pages 1132-1137

  Lancon A ^a   Delma, D ^a   Osman, H ^a,b   Thenot J P ^a,b   Jannin, B ^a   Latruffe, N ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b SANOFI   (France)

Author keywords

Bioavailability; Fluorescence microscopy; HepG2; Human hepatocytes; Resveratrol; Uptake

Indexed keywords

RESVERATROL;

ARTICLE; CELL STRAIN HEPG2; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG UPTAKE; HUMAN; HUMAN CELL; LIVER CELL; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; TEMPERATURE DEPENDENCE; TUMOR CELL;

BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT, ACTIVE; CARRIER PROTEINS; CELL LINE; CELL LINE, TUMOR; DIFFUSION; HEPATOBLASTOMA; HEPATOCYTES; HUMANS; METABOLIC CLEARANCE RATE; STILBENES; TEMPERATURE; TISSUE DISTRIBUTION;

EID: 1642381216     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.164     Document Type: Article

References (27)

1. Frémont L. Biological effects of resveratrol. Life Sci. 66:2000;663-673.
2. Aziz M.H., Kumar R., Ahmad N. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int. J. Oncol. 23:2003;17-28.
3. Sun A.Y., Simonyi A., Sun G.Y. The French Paradox and beyond: neuroprotective effects of polyphenols. Free Radic. Biol. Med. 32:2002;314-318.
4. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220.
5. Delmas D., Jannin B., Cherkaoui Malki M., Latruffe N. Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines. Oncol. Rep. 7:2000;847-852.
6. Sun Z.J., Pan C.E., Liu H.S., Wang G.J. Anti-hepatoma activity of resveratrol in vitro. World J. Gastroenterol. 8:2002;79-81.
7. Kuo P.L., Chiang L.C., Lin C.C. Resveratrol-induced apoptosis is mediated by p53-dependent pathway in HepG2 cells. Life Sci. 72:2002;23-34.
8. Delmas D., Passilly-Degrace P., Jannin B., Cherkaoui-Malki M., Latruffe N. Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells. Int. J. Mol. Med. 10:2002;193-199.
9. Delmas D., Rebe C., Lacour S., Filomenko R., Athias A., Gambert P., Cherkaoui-Malki M., Jannin B., Dubrez-Daloz L., Latruffe N., Solary E. Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death inducing signaling complex in colon cancer cells. J. Biol. Chem. 278:2003;41482-41490.
10. De Ledinghen V., Monvoisin A., Neaud V., Krisa S., Payrastre B., Bedin C., Desmoulière A., Bioulac-Sage P., Rosenbaum J. Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells. Int. J. Oncol. 19:2001;83-88.
11. Kozuki Y., Miura Y., Yagasaki K. Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action. Cancer Lett. 167:2001;151-156.
12. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., Scherer B., Sinclair D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 425:2003;191-196.
13. Andlauer W., Kolb J., Siebert K., Fürst P. Assessment of resveratrol bioavailability in the perfused small intestine of the rat. Drugs Exp. Clin. Res. 26:2000;47-55.
14. Kuhnle G., Spencer J.P.E., Chowrimootoo G., Schroeter H., Debnam E.S., Srai S.K.S., Rice-Evans C., Hahn U. Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem. Biophys. Res. Commun. 272:2000;212-217.
15. Bertelli A., Bertelli A.A.E., Gozzini A., Giovannini L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp. Clin. Res. 24:1998;133-138.
16. Soleas G.J., Angelini M., Grass L., Diamandis E.P., Goldberg D.M. Absorption of trans-resveratrol in rats. Methods Enzymol. 335:2001;145-154.
17. Asensi M., Medina I., Ortega A., Carretero J., Baño M.C., Obrador E., Estrela J.M. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic. Biol. Med. 33:2002;387-398.
18. Marier J.-F., Vachon P., Gritsas A., Zhang J., Moreau J.-P., Ducharme M.P. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J. Pharmacol. Exp. Ther. 302:2002;369-373.
19. 14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 72:2003;2219-2233.
20. Kaldas M.I., Walle U.K., Walle T. Resveratrol transport and metabolism by human intestinal Caco-2 cells. J. Pharm. Pharmacol. 55:2002;307-312.
21. Goldberg D.M., Yan J., Soleas G.J. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 36:2003;79-87.
22. Guy R., Scott Z., Sloboda R., Nicolaou K. Fluorescent taxoids. Chem. Biol. 3:1996;1021-1031.
23. ′ -tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts Carcinogenesis. 22:2001;321-328.
24. Gao X., Xu Y.X., Divine G., Janakiraman N., Chapman R.A., Gautam S.C. Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. J. Nutr. 132:2002;2076-2081.
25. Chen T., Li J., Cao J., Xu Q., Komatsu K., Namba T. A new flavanone isolated from Rhizoma smilacis glabrae and the structural requirements of its derivatives for preventing immunological hepatocyte damage. Planta Med. 65:1999;56-59.
26. Yu C., Shin Y.G., Chow A., li Y., Kosmeder J.W., Lee Y.S., Hischelman W.H., Pezzuto J.M., Mehta R.G., van Breemen R.B. Human, rat and mouse metabolism of resveratrol. Pharm. Res. 19:2002;1907-1914.
27. Glatz J.F.C., van der Vusse G.J. Cellular fatty-acid binding proteins: their function and physiological significance. Prog. Lipid. Res. 35:1996;243-282.